Literature DB >> 19189191

Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer.

In Kyu Lee1, Do Hyoung Kim, D Lee Gorden, Yoon Suk Lee, Na Young Sung, Gyeoung-Sin Park, Hyung Jin Kim, Won Kyung Kang, Jong Kyung Park, Chang Hyeok Ahn, Jun-Gi Kim, Hae Myung Jeon, Seong Taek Oh.   

Abstract

BACKGROUND: Early diagnosis and management of peritoneal metastases from colorectal cancer patients are difficult clinical challenges. The aims of this study were to evaluate the clinical significance of tumor markers and cytology in peritoneal effusions (PE) and peritoneal irrigation fluid (PI) and to determine their value as prognostic indicators in this disease.
METHODS: Two hundred thirty-four consecutive patients who underwent abdominal surgery for colorectal cancer from January 2006 to December 2007 were included, and tumor markers and cytology in PE and PI were analyzed prospectively.
RESULTS: The incidence of free cancer cells retrieved from peritoneal samples was 7.9%. Cytology was positive in 40.0% by Papanicolaou and Giemsa staining, 73.3% by hematoxylin and eosin staining of cell blocks, and 66.7% by carcinoembryonic antigen (CEA) and calretinin immunohistochemistry. Multivariate analysis revealed that peritoneal CEA and cancer antigen (CA) 19-9 in PI were correlated with peritoneal metastasis and cytology. Level of peritoneal fluid CEA was statistically significantly correlated with recurrence and peritoneal metastatic recurrence in patients with negative peritoneal cytology. Cytology, peritoneal CEA, and peritoneal CA 19-9 showed correlations with cancer-free survival and overall survival.
CONCLUSIONS: These correlations demonstrate the importance of continuous follow-up of peritoneal metastasis if there is positive cytology or an increase in CEA and CA 19-9 in peritoneal fluid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189191     DOI: 10.1245/s10434-008-0294-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.

Authors:  Yoichiro Homma; Takashi Hamano; Yasuhiro Akazawa; Yoshiro Otsuki; Shinichi Shimizu; Hiroshi Kobayashi; Shingo Kameoka; Yasuyuki Kobayashi
Journal:  Surg Today       Date:  2013-08-14       Impact factor: 2.549

2.  Feasibility of CYFRA 21-1 as a serum biomarker for the detection of colorectal adenoma and advanced colorectal adenoma in people over the age of 45.

Authors:  Do Hyoung Lim; Jai Hyuen Lee; Jong Wan Kim
Journal:  J Clin Lab Anal       Date:  2017-02-10       Impact factor: 2.352

Review 3.  Intra-operative peritoneal lavage for colorectal cancer.

Authors:  Guillaume Passot; Kayvan Mohkam; Eddy Cotte; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study.

Authors:  Byung Chul Kim; Jung Hoon Bae; Sun Min Park; Dae Youn Won; In Kyu Lee
Journal:  Int J Colorectal Dis       Date:  2019-12-05       Impact factor: 2.571

Review 5.  Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer.

Authors:  Takeshi Nishikawa; Eiji Sunami; Toshiaki Tanaka; Junichiro Tanaka; Tomomitsu Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hiroaki Nozawa; Soichiro Ishihara; Toshiaki Watanabe
Journal:  Surg Today       Date:  2014-11-07       Impact factor: 2.549

6.  Lack of prognostic role of pre- and postoperative peritoneal cytology and cytokeratin PCR-expression on local recurrence after curative anterior resection for mid-low rectal cancer.

Authors:  Donato F Altomare; Michele Tedeschi; Maria-Teresa Rotelli; Domenica Bocale; Domenico Piscitelli; Marcella Rinaldi
Journal:  Updates Surg       Date:  2011-04-20

7.  Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.

Authors:  Wang Likui; Wang Hong; Zhang Shuwen
Journal:  J Gastrointest Surg       Date:  2009-09-18       Impact factor: 3.452

8.  Clinical significance of carcinoembryonic antigen in peritoneal fluid detected during operation in stage I-III colorectal cancer patients.

Authors:  Jae Hyun Kim; Seunghun Lee; Seung Hyun Lee; Byung Kwon Ahn; Sung Uhn Baek; Won Moon; Seun Ja Park
Journal:  Intest Res       Date:  2018-07-27

9.  The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.

Authors:  Mingfei Zhao; Feng Liang; Buyi Zhang; Wei Yan; Jianmin Zhang
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

10.  Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives.

Authors:  Charlotte E L Klaver; Roos Stam; Didi A M Sloothaak; Johannes Crezee; Willem A Bemelman; Cornelis J A Punt; Pieter J Tanis
Journal:  Oncotarget       Date:  2017-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.